Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-121206
Filing Date
2024-11-05
Accepted
2024-11-05 12:06:18
Documents
1
Period of Report
2024-11-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8407
  Complete submission text file 0000950170-24-121206.txt   10423
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Reporting) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37410 | Film No.: 241426425

Mailing Address ARA HILL TOP BUILDING, UNIT A-5 PLETTERIJWEG OOST 1, CURACAO WILLEMSTAD P8 000000
Business Address
BIOTECH GROWTH N V (Reporting) CIK: 0001259869 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37410 | Film No.: 241426426

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)